Generation of retinal pigment epithelial cells from small molecules and OCT4 reprogrammed human induced pluripotent stem cells

Tim U. Krohne, Peter D. Westenskow, Toshihide Kurihara, David F. Friedlander, Mandy Lehmann, Alison L. Dorsey, Wenlin Li, Saiyong Zhu, Andrew Schultz, Junhua Wang, Gary Siuzdak, Sheng Ding, Martin Friedlander

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Autologous retinal pigment epithelium (RPE) grafts derived from induced pluripotent stem cells (iPSCs) may be used to cure blinding diseases in which RPE dysfunction results in photoreceptor degeneration. Four-, two-, and one-factor-derived iPSCs (4F-, 2F-, and 1F-iPSCs, respectively) were differentiated into fully functional cuboidal pigmented cells in polarized monolayers that express RPE-specific markers. 1F-iPSC-RPE (1F-iPS-RPE) strongly resembles primary human fetal RPE (hfRPE) based on proteomic and untargeted metabolomic analyses, and using novel in vivo imaging technology coupled with electroretinography, we demonstrated that 1F-iPS-RPE mediate anatomical and functional rescue of photoreceptors after transplantation in an animal model of RPE-mediated retinal degeneration. 1F-iPS-RPE cells were injected subretinally as a suspension and formed a monolayer dispersed between host RPE cells. Furthermore, 1F-iPS-RPE do not simply provide trophic support to rescue photoreceptors as previously speculated but actually phagocytose photoreceptor outer segments in vivo and maintain visual cycling. Thus, 1F-iPS-RPE grafts may be superior to conventional iPS-RPE for clinical use because 1F-iPS-RPE closely resemble hfRPE, mediate anatomical and functional photoreceptor rescue in vivo, and are generated using a reduced number of potentially oncogenic reprogramming factors.

Original languageEnglish
Pages (from-to)96-109
Number of pages14
JournalStem cells translational medicine
Volume1
Issue number2
DOIs
Publication statusPublished - 2012

Fingerprint

Induced Pluripotent Stem Cells
Retinal Pigments
Retinal Pigment Epithelium
Epithelial Cells
Transplants
Electroretinography
Retinal Degeneration
Metabolomics
Phagocytosis
Proteomics

Keywords

  • Aging
  • Differentiation
  • Induced pluripotent stem cells
  • Retina
  • Small molecules
  • Stem cell transplantation

ASJC Scopus subject areas

  • Cell Biology
  • Developmental Biology

Cite this

Krohne, T. U., Westenskow, P. D., Kurihara, T., Friedlander, D. F., Lehmann, M., Dorsey, A. L., ... Friedlander, M. (2012). Generation of retinal pigment epithelial cells from small molecules and OCT4 reprogrammed human induced pluripotent stem cells. Stem cells translational medicine, 1(2), 96-109. https://doi.org/10.5966/sctm.2011-0057

Generation of retinal pigment epithelial cells from small molecules and OCT4 reprogrammed human induced pluripotent stem cells. / Krohne, Tim U.; Westenskow, Peter D.; Kurihara, Toshihide; Friedlander, David F.; Lehmann, Mandy; Dorsey, Alison L.; Li, Wenlin; Zhu, Saiyong; Schultz, Andrew; Wang, Junhua; Siuzdak, Gary; Ding, Sheng; Friedlander, Martin.

In: Stem cells translational medicine, Vol. 1, No. 2, 2012, p. 96-109.

Research output: Contribution to journalArticle

Krohne, TU, Westenskow, PD, Kurihara, T, Friedlander, DF, Lehmann, M, Dorsey, AL, Li, W, Zhu, S, Schultz, A, Wang, J, Siuzdak, G, Ding, S & Friedlander, M 2012, 'Generation of retinal pigment epithelial cells from small molecules and OCT4 reprogrammed human induced pluripotent stem cells', Stem cells translational medicine, vol. 1, no. 2, pp. 96-109. https://doi.org/10.5966/sctm.2011-0057
Krohne, Tim U. ; Westenskow, Peter D. ; Kurihara, Toshihide ; Friedlander, David F. ; Lehmann, Mandy ; Dorsey, Alison L. ; Li, Wenlin ; Zhu, Saiyong ; Schultz, Andrew ; Wang, Junhua ; Siuzdak, Gary ; Ding, Sheng ; Friedlander, Martin. / Generation of retinal pigment epithelial cells from small molecules and OCT4 reprogrammed human induced pluripotent stem cells. In: Stem cells translational medicine. 2012 ; Vol. 1, No. 2. pp. 96-109.
@article{02edb6abf73d4f3ca1c14e35474e74b9,
title = "Generation of retinal pigment epithelial cells from small molecules and OCT4 reprogrammed human induced pluripotent stem cells",
abstract = "Autologous retinal pigment epithelium (RPE) grafts derived from induced pluripotent stem cells (iPSCs) may be used to cure blinding diseases in which RPE dysfunction results in photoreceptor degeneration. Four-, two-, and one-factor-derived iPSCs (4F-, 2F-, and 1F-iPSCs, respectively) were differentiated into fully functional cuboidal pigmented cells in polarized monolayers that express RPE-specific markers. 1F-iPSC-RPE (1F-iPS-RPE) strongly resembles primary human fetal RPE (hfRPE) based on proteomic and untargeted metabolomic analyses, and using novel in vivo imaging technology coupled with electroretinography, we demonstrated that 1F-iPS-RPE mediate anatomical and functional rescue of photoreceptors after transplantation in an animal model of RPE-mediated retinal degeneration. 1F-iPS-RPE cells were injected subretinally as a suspension and formed a monolayer dispersed between host RPE cells. Furthermore, 1F-iPS-RPE do not simply provide trophic support to rescue photoreceptors as previously speculated but actually phagocytose photoreceptor outer segments in vivo and maintain visual cycling. Thus, 1F-iPS-RPE grafts may be superior to conventional iPS-RPE for clinical use because 1F-iPS-RPE closely resemble hfRPE, mediate anatomical and functional photoreceptor rescue in vivo, and are generated using a reduced number of potentially oncogenic reprogramming factors.",
keywords = "Aging, Differentiation, Induced pluripotent stem cells, Retina, Small molecules, Stem cell transplantation",
author = "Krohne, {Tim U.} and Westenskow, {Peter D.} and Toshihide Kurihara and Friedlander, {David F.} and Mandy Lehmann and Dorsey, {Alison L.} and Wenlin Li and Saiyong Zhu and Andrew Schultz and Junhua Wang and Gary Siuzdak and Sheng Ding and Martin Friedlander",
year = "2012",
doi = "10.5966/sctm.2011-0057",
language = "English",
volume = "1",
pages = "96--109",
journal = "Stem cells translational medicine",
issn = "2157-6564",
publisher = "AlphaMed Press",
number = "2",

}

TY - JOUR

T1 - Generation of retinal pigment epithelial cells from small molecules and OCT4 reprogrammed human induced pluripotent stem cells

AU - Krohne, Tim U.

AU - Westenskow, Peter D.

AU - Kurihara, Toshihide

AU - Friedlander, David F.

AU - Lehmann, Mandy

AU - Dorsey, Alison L.

AU - Li, Wenlin

AU - Zhu, Saiyong

AU - Schultz, Andrew

AU - Wang, Junhua

AU - Siuzdak, Gary

AU - Ding, Sheng

AU - Friedlander, Martin

PY - 2012

Y1 - 2012

N2 - Autologous retinal pigment epithelium (RPE) grafts derived from induced pluripotent stem cells (iPSCs) may be used to cure blinding diseases in which RPE dysfunction results in photoreceptor degeneration. Four-, two-, and one-factor-derived iPSCs (4F-, 2F-, and 1F-iPSCs, respectively) were differentiated into fully functional cuboidal pigmented cells in polarized monolayers that express RPE-specific markers. 1F-iPSC-RPE (1F-iPS-RPE) strongly resembles primary human fetal RPE (hfRPE) based on proteomic and untargeted metabolomic analyses, and using novel in vivo imaging technology coupled with electroretinography, we demonstrated that 1F-iPS-RPE mediate anatomical and functional rescue of photoreceptors after transplantation in an animal model of RPE-mediated retinal degeneration. 1F-iPS-RPE cells were injected subretinally as a suspension and formed a monolayer dispersed between host RPE cells. Furthermore, 1F-iPS-RPE do not simply provide trophic support to rescue photoreceptors as previously speculated but actually phagocytose photoreceptor outer segments in vivo and maintain visual cycling. Thus, 1F-iPS-RPE grafts may be superior to conventional iPS-RPE for clinical use because 1F-iPS-RPE closely resemble hfRPE, mediate anatomical and functional photoreceptor rescue in vivo, and are generated using a reduced number of potentially oncogenic reprogramming factors.

AB - Autologous retinal pigment epithelium (RPE) grafts derived from induced pluripotent stem cells (iPSCs) may be used to cure blinding diseases in which RPE dysfunction results in photoreceptor degeneration. Four-, two-, and one-factor-derived iPSCs (4F-, 2F-, and 1F-iPSCs, respectively) were differentiated into fully functional cuboidal pigmented cells in polarized monolayers that express RPE-specific markers. 1F-iPSC-RPE (1F-iPS-RPE) strongly resembles primary human fetal RPE (hfRPE) based on proteomic and untargeted metabolomic analyses, and using novel in vivo imaging technology coupled with electroretinography, we demonstrated that 1F-iPS-RPE mediate anatomical and functional rescue of photoreceptors after transplantation in an animal model of RPE-mediated retinal degeneration. 1F-iPS-RPE cells were injected subretinally as a suspension and formed a monolayer dispersed between host RPE cells. Furthermore, 1F-iPS-RPE do not simply provide trophic support to rescue photoreceptors as previously speculated but actually phagocytose photoreceptor outer segments in vivo and maintain visual cycling. Thus, 1F-iPS-RPE grafts may be superior to conventional iPS-RPE for clinical use because 1F-iPS-RPE closely resemble hfRPE, mediate anatomical and functional photoreceptor rescue in vivo, and are generated using a reduced number of potentially oncogenic reprogramming factors.

KW - Aging

KW - Differentiation

KW - Induced pluripotent stem cells

KW - Retina

KW - Small molecules

KW - Stem cell transplantation

UR - http://www.scopus.com/inward/record.url?scp=84860622908&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860622908&partnerID=8YFLogxK

U2 - 10.5966/sctm.2011-0057

DO - 10.5966/sctm.2011-0057

M3 - Article

VL - 1

SP - 96

EP - 109

JO - Stem cells translational medicine

JF - Stem cells translational medicine

SN - 2157-6564

IS - 2

ER -